Literature DB >> 23919592

Intra-abdominal fat is related to metabolic syndrome and non-alcoholic fat liver disease in obese youth.

Loreana Sanches Silveira1, Paula Alves Monteiro, Bárbara de Moura Mello Antunes, Patrícia Monteiro Seraphim, Rômulo Araújo Fernandes, Diego G Destro Christofaro, Ismael F Freitas Júnior.   

Abstract

BACKGROUND: Previous studies have shown an association between adiposity, especially intra-abdominal adipose tissue, and hemodynamic/metabolic comorbidities in adults, however it is not clear in pediatric population. The aim of the study was to analyze the relationship between non-alcoholic fatty liver disease (NAFLD) and components of metabolic syndrome (MS) with values of intra-abdominal (IAAT) and subcutaneous (SCAT) adipose tissue in obese children and adolescents.
METHODS: Cross-sectional study.
SUBJECTS: 182 obese sedentary children and adolescents (aged 6 to 16 y), identified by the body mass index (BMI). MEASUREMENTS: Body composition and trunk fat by dual-energy X-ray absorptiometry- DXA; lipid profile, blood pressure and pubertal stage were also assessed. NAFLD was classified as absent (0), mild (1), moderate (2) and severe (3), and intra-abdominal and subcutaneous abdominal fat thickness were identified by ultrasound. The MS was identified according to the cut offs proposed by World Health Organization adapted for children and adolescents. The chi-square test was used to compare categorical variables, and the binary logistic regression indicated the magnitude of the associations adjusted by potential cofounders (sex, age, maturation, NAFLD and HOMA-IR).
RESULTS: Higher quartile of SCAT was associated with elevated blood pressure (p = 0.015), but not associated with NAFLD (p = 0.665). Higher IAAT was positively associated with increased dyslipidemia (p = 0.001), MS (p = 0.013) and NAFLD (p = 0.005). Intermediate (p = 0.007) and highest (p = 0.001) quartile of IAAT were also associated with dyslipidemia, independently of age, sex, maturation, NAFLD and HOMA-IR (homeostatic model assessment-insulin resistance).
CONCLUSION: Obese children and adolescents, with higher IAAT are more prone to develop MS and NAFLD than those with higher values of SCAT, independent of possible confounding variables.

Entities:  

Mesh:

Year:  2013        PMID: 23919592      PMCID: PMC3751250          DOI: 10.1186/1471-2431-13-115

Source DB:  PubMed          Journal:  BMC Pediatr        ISSN: 1471-2431            Impact factor:   2.125


Background

Changes observed in modern society in the last decades have led to increasing prevalence of childhood obesity in developed and developing countries [1]. Pediatric obesity is associated with a large variety of metabolic/hemodynamic comorbidities, such as the metabolic syndrome (MS) and non-alcoholic fat liver disease (NAFLD) [2,3]. Deeper analysis have shown that, not only the total, but the distribution of excessive adipose tissue seems to determine the development of these comorbidities and, therefore, abdominal obesity (intra-abdominal adipose tissue [IAAT]) is point out as more harmful to human health than subcutaneous adipose tissue (SCAT) [4,5]. It is well documented that adulthood health is affected by risk factors which may determine cardiovascular diseases, such as dyslipidaemia, diabetes type II and hypertension at early age [6-8] and is fundamental to detect these potential risk factors to prevent or treat obesity. On the other hand, it is not clear whether the above mentioned influence of body fat distribution occur among obese children and adolescents, due to the lack of research about the relationship between IAAT and SCAT with MS and NAFLD in these populations. The purpose of the present study is to analyze the relationship of NAFLD and components of MS with values of IAAT and SCAT, in a sample of sedentary obese children and adolescents.

Methods

Participants and setting

The present study included 182 children and adolescents of both genders (51.6% females), who met the inclusion criteria: (a) obesity identified by body mass index (BMI) according to Cole et al. (2000) [9], (b) aged between 6 and 16 years (at evaluation date) and (c) no regular physical activity practice in the last three months prior to the assessment and no disease or limitation that does not allowed the practice (d) sign a written informed consent form for the participation in the study (participants and parents/guardians). The number of participants at each age ranged from 20 (6 and 7 years), 44 (8 and 9 years), 51 (10 to 12 years) 48 (13 and 14 years) and 19 (15 and 16 years). The ethical committee of the FCT/UNESP approved this study (Protocol number 07/2009).

Anthropometry

Body weight (BW) was measured with an electronic scale (precision 0.1 kg [Filizzola PL 150, Filizzola® Ltda]) and the height with a wall-mounted stadiometer (precision 0.1 cm [Sanny®, São Paulo, Brazil]), with the subjects wearing light clothing and no shoes. Anthropometric measurements were performed by trained researchers, according to standardized techniques [10].

Dual energy X-ray absorptiometry

Percentage of body fat (%BF) and amount of trunk fat mass (TFM [kg]) were estimated by a Dual-energy X-ray absorptiometry- DXA scanner (Lunar DPX-NT; General Electric Healthcare, Little Chalfont, Buckinghamshire [software version 4.7]). The measurement took approximately 15 minutes and the subjects remained in a supine position during the scanning, wearing light clothing while lying flat on their back with arms by the side, without moving during the measurement. The results were transmitted to a connected computer for further analysis, according to the manufacturer orientation. All Dual-energy X-ray absorptiometry- DXA measurements were made at the laboratory of the São Paulo State University Campus of Presidente Prudente, in a room with controlled temperature. Each morning before beginning the measurements, the equipment was calibrated by the same researcher and, according to the references provided by the manufacturer.

Pubertal stages

Pubertal stage was self-assessed by the participants aged older than 10 years. A standardized series of drawings was given to the subjects to assess their own pubertal development according to Tanner, et al. (1969, 1970) [11,12]. Girls received drawings with the five pubertal stages of Tanner with breast and female pubic hair development, with appropriate descriptions. Boys received drawings with the five pubertal stages of Tanner with male genitalia and pubic hair development, with appropriate descriptions. It was asked to the subjects to select the drawing stage that best indicated his/her own development. The results were placed in a locked box by each subject to guarantee the integrity and anonymity of the subjects. The five stages of Tanner of pubic hair development were grouped in three classifications: Group 1 = subjects aged under 10 years and those who answered stage 1; Group 2 = subjects who answered stages 2 and 3; Group 3 = Subjects who answered stages 4 and 5.

Blood samples

After a 12 hour fasting, blood samples were collected, by nurses, on tubes containing EDTA, an anticoagulant for blood samples. All blood samples were analysed in a private laboratory. Triglycerides, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), insulin and glucose were analysed, using the colorimetric method (dyslipidemia was identified as any modification in the lipid variables). The dosage of insulin was performed using the Elisa Kit (RayBio® Human Insulin ELISA Kit), according to the manufacturer instructions.

Blood pressure

Systolic blood pressure (SBP) and diastolic blood pressure (DBP) values were measured with an electronic device (MX3Plus; Omron Corporation, Kyoto, Kansai, Japan), previously validated for pediatric populations [13]. The measurements were taken after 15 minutes of rest in a sitting position. Two measures were taken on the right arm, with a 2-minute interval between them and mean value of both measures was used. Two types of cuffs were used according to arm circumference. The classification of elevated blood pressure (EBP) was made by 95th centile or higher for age, gender and height, according to National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (NHBPEP, 2004) [14].

Metabolic syndrome

The presence of MS was identified according to the cut offs proposed by World Health Organization adapted for children and adolescents [15]. The diagnosis of MS was based in the presence of, at least, three criteria. 1) Obesity: BMI ≥ 95th centile; 2) Glucose homeostasis: defined by hyperinsulinemia according to the norms for pubertal stage: pre-pubertal ≥15 mU/L, mid-puberty (stages 2–3) ≥ 30 mU/L [16], and post-pubertal ≥20 mU/L (adult value) and/or fasting glucose ≥ 110 mg/dL; 3) Hypertension: systolic blood pressure (SBP) ≥ 95th centile for age, gender and height [14]; 4) Dyslipidaemia: triglycerides >155 mg/dL, high density lipoprotein (HDL) < 35 mg/dL and total cholesterol ≥ 95th centile. Homeostasis model assessment-insulin resistance (HOMA-IR) was calculated according to the formula proposed by Matthews et al. (1985) [17]: HOMA-IR = Fasting insulin (mU/mL) X fasting glucose (mgl/dL)/405.

Ultrasound

An ultrasound equipment (Toshiba Aplio Model Tochigi-ken, Japan) was used to assess the fat accumulation and the morphology of the liver (size of the left and right lobes), by a specialist medical doctor. NAFLD was stratified as followed: absent (0), mild (level 1), moderate (level 2) and severe (level 3). However, the sample was dichotomized: Absence and Presence, because of the lack of subjects with severe level. The ultrasound also measured intra-abdominal (IAAT) and subcutaneous (SCAT) abdominal adipose tissue thickness (cm). The values of IAAT and SCAT were stratified into quartile (Quartile1; Quartile2-3; Quartile4).

Statistical analysis

Numerical variables were presented as mean and standard deviation. Test-T was used for comparison of the general variables between sexes. Chi-square test compared the categorical variables. Binary logistic regression (odds ratio [OR] and 95% confidence interval [OR95%CI]) indicated the magnitude of the associations adjusted by potential confounders (sex, age, maturation, classification of NAFLD and HOMA-IR). Statistical significance was set at 5% and the Statistical Package for Social Science, version 17.0 (SPSS Inc, Chicago, Illinois) was used for all analyses.

Results

The comparison between male and female subjects (Table 1), showed similarity for age (p = 0.994), all biochemical variables, including, insulin resistance (p = 0.356) and dyslipidemia (p = 0.391) and blood pressure at rest (SBP with p = 0.426 and DBP with p = 0.551) and elevated (p = 0.740). The prevalence of MS was high in both genders (male 52.3% and female: 42.6%; p = 0.381). Boys presented lower percentage of body fatness (p = 0.012), however, higher IAAT than girls (p = 0.001).
Table 1

General characteristics of obese youth stratified by sex (n = 182)

 Total (n = 182)Male (n = 88)Female (n = 94)P
 
Mean (SD)
Mean (SD)
Mean (SD)
 
Age (years)
11.0 (2.7)
11.1 (2.8)
11.1 (2.7)
0.994
Fasting glucose (mg/dL)
82.0 (7.1)
82.7 (7.2)
81.1 (6.9)
0.126
Triglycerides (mg/dL)
115.11 (51.3)
117.7 (58.5)
112.6 (43.7)
0.507
Cholesterol (mg/dL)
163.5 (32.9)
164.8 (36.3)
162.3 (29.4)
0.601
HDL-C (mg/dL)
43.1 (9.9)
42.9 (10.4)
43.3 (9.4)
0.771
LDL-C (mg/dL)
97.4 (28.9)
98.4 (31.8)
96.4 (25.9)
0.641
IAAT (cm)
4.4 (1.6)
4.81 (1.65)
3.97 (1.34)
0.001
SCAT (cm)
3.3 (1.4)
3.34 (1.55)
3.22 (1.28)
0.550
%BF
46.1 (5.4)
44.6 (5.5)
46.6 (4.8)
0.012
TrunkBF (kg)
17.9 (6.9)
15.2 (7.1)
14.3 (7.8)
0.440
SBP (mmHg)
116.3 (19.6)
117.5 (22.4)
115.2 (16.5)
0.426
DBP (mmHg)
69.0 (11.9)
68.4 (13.4)
69.5 (10.2)
0.551
NAFLD (%)
26.4
36,4
17.0
0.005
MS components (%)
 
 
 
 
Hyperinsulinemia
65.4
69.3
61.7
0.356
EBP
35.7
37.5
34
0.740
Dyslipidemia
46.2
50
42.6
0.391
MS48.452.344.70.381

SD standard-deviation, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, SBP systolic blood pressure; DBP diastolic blood pressure, IAAT intra-abdominal adipose tissue, SCAT subcutaneous adipose tissue, %BF percentage of body fatness, EBP elevated blood pressure, MS metabolic syndrome, NAFLD non-alcoholic fat liver disease.

General characteristics of obese youth stratified by sex (n = 182) SD standard-deviation, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, SBP systolic blood pressure; DBP diastolic blood pressure, IAAT intra-abdominal adipose tissue, SCAT subcutaneous adipose tissue, %BF percentage of body fatness, EBP elevated blood pressure, MS metabolic syndrome, NAFLD non-alcoholic fat liver disease. Higher quartile of SCAT was associated with EBP (chi-square with p = 0.015 (Table 2), but not with NAFLD (p = 0.665). However, IAAT was positively associated with increased occurrence of dyslipidemia (p = 0.001), MS (p = 0.013) and NAFLD (p = 0.005). Hyperinsulinemia was not associated with SCAT and IAAT. The classification of NAFLD was positively associated with insulin resistance (Table 3), and marginally associated with MS (p = 0.075).
Table 2

Association between abdominal adipose tissue, non-alcoholic fatty liver disease and metabolic syndrome in obese youth (n = 182)

 
Subcutaneous abdominal adipose tissue (Quartile)
P
MS components<P25P25-P75≥P75
  Hyperinsulinemia
66.7%
63.3%
68%
0.866
  EBP
28.6%
30%
52%
0.015
  Dyslipidemia
50%
51.1%
34%
0.108
  MS
45.2%
45.6%
56%
0.285
  NAFLD
21.4%
28.9%
26%
0.665
 
Intra-abdominal adipose tissue (Quartile)
P
MS components
<P25
P25-P75
≥P75
  Hyperinsulinemia
58.5%
66.3%
69.6%
0.287
  EBP
31.7%
32.6%
45.7%
0.165
  Dyslipidemia
22%
49.5%
60.9%
0.001
  MS
34.1%
48.4%
60.9%
0.013
 NAFLD14.6%24.2%41.3%0.005

P25 25th percentile; P75 = 75th percentile, EBP elevated blood pressure, MS metabolic syndrome, NAFLD non-alcoholic fat liver disease.

Table 3

Association between non-alcoholic fatty liver disease and metabolic syndrome components in obese children and adolescents (n = 182)

 
Non-alcoholic fatty liver disease
P
MS componentsNoYes
  Hyperinsulinemia
60.4%
79.2%
0.031
  EBP
35.1%
37.5%
0.900
  Dyslipidemia
42.5%
56.3%
0.143
MS44%60.4%0.075

EBP elevated blood pressure, MS metabolic syndrome.

Association between abdominal adipose tissue, non-alcoholic fatty liver disease and metabolic syndrome in obese youth (n = 182) P25 25th percentile; P75 = 75th percentile, EBP elevated blood pressure, MS metabolic syndrome, NAFLD non-alcoholic fat liver disease. Association between non-alcoholic fatty liver disease and metabolic syndrome components in obese children and adolescents (n = 182) EBP elevated blood pressure, MS metabolic syndrome. In the multivariate model, statistically significant associations in the chi-square test were analyzed under adjustment of potential confounders (sex, age, maturation, presence of NAFLD and HOMA-IR). The association between higher quartile of SCAT and EBP did not reach statistical significance, in both adjusted models (Model 1- OR = 1.86 [0.70 – 4.91]; p = 0.210; Model 2- OR = 1.90 [0.71 – 5.05]; p = 0.195). On the other hand, both intermediate (OR = 3.33 [1.39 – 8.00]; p = 0.007) and highest (OR = 5.23 [1.92 – 14.2]; p = 0.001) quartile of IAAT were significantly associated to dyslipidemia, independently of age, sex, maturation, NAFLD and HOMA-IR (Table 4).
Table 4

Multivariate model for association between abdominal adipose tissue and metabolic syndrome components (n = 182)

Abdominal adipose tissueBinary logistic regression
Binary logistic regression
Binary logistic regression
Model – 1Model – 2Model – 3
 
SCAT
OR (OR95%CI)
p
OR (OR95%CI)
p
OR (OR95%CI)
p
EBP
  <P25
1.00
---
1.00
---
1.00
---
 
  P25-75
1.07 (0.47 – 2.41)
0.867
0.89 (0.38 – 2.07)
0.795
0.88 (0.38 – 2.05)
0.776
 
  ≥P75
2.71 (1.13 – 6.46)
0.025
1.86 (0.70 – 4.91)
0.210
1.90 (0.71 – 5.05)
0.195
 
IAAT
OR (OR95%CI)
p
OR (OR95%CI)
p
OR (OR95%CI)
p
Dyslipidemia
  <P25
1.00
---
1.00
---
1.00
---
 
  P25-75
3.48 (1.50 – 8.07)
0.004
3.48 (1.46 – 8.31)
0.005
3.33 (1.39 – 8.00)
0.007
   ≥P755.53 (2.14 – 14.2)0.0015.65 (2.09 – 15.2)0.0015.23 (1.92 – 14.2)0.001

Model-1: crude analysis; Model-2: analysis adjusted by sex, age and maturation; Model-3: analysis adjusted by sex, age, maturation, NAFLD and HOMA-IR; EBP elevated blood pressure, NAFLD non-alcoholic fat liver disease, OR odds ratio, 95% CI 95% confidence interval, IAAT intra-abdominal adipose tissue, SCAT subcutaneous adipose tissue, EBP elevated blood pressure, MS metabolic syndrome.

Multivariate model for association between abdominal adipose tissue and metabolic syndrome components (n = 182) Model-1: crude analysis; Model-2: analysis adjusted by sex, age and maturation; Model-3: analysis adjusted by sex, age, maturation, NAFLD and HOMA-IR; EBP elevated blood pressure, NAFLD non-alcoholic fat liver disease, OR odds ratio, 95% CI 95% confidence interval, IAAT intra-abdominal adipose tissue, SCAT subcutaneous adipose tissue, EBP elevated blood pressure, MS metabolic syndrome.

Discussion

Despite seeming higher in obese youth, MS prevalence is not clear, because there is not yet a standard reference table worldwide accepted [18]. In our obese sample, boys (52.3%) and girls (44.7%) presented higher prevalence of the outcome than in another study with obese Brazilian adolescents (27,6%) [19] that used the same classification for MS. Moreover, the prevalence of NAFLD in our obese sample (26.4%) was similar to those recently observed in other overweight/obese adolescents (27,7%) [20]. Therefore, MS and NAFLD should be a relevant concern in developing countries, which experienced rapid industrialization process during the last decades, but without a consistent health politics related to nutrition and promotion of physical activity. NAFLD was significantly associated with increased fasting insulin and glucose and marginally with MS. Previously, Ayonrinde et al. (2011) [21] identified in 1170 Australian adolescents that fat accumulation in the liver is related to decreased values of insulin. Other components of MS presented similar result of association with NAFLD, which is in accordance with previous studies, that refers to NAFLD as the “hepatic manifestation” of the MS [22]. Regarding the association between IAAT and dyslipidemia, the scientific literature has offered support to the idea that insulin resistance plays key role in the genesis of the NAFLD and components of MS [4], mainly in cases when the abdominal obesity is present. Adipose tissue has an endocrine function that produces multiple adipokines causing inflammatory process and insulin resistance [4,23,24]. Visceral adipose tissue located at abdominal region has particularities related to higher lipolysis, higher release of adipokines and these characteristics increase its atherosclerotic capacity [4]. Adipokines like tumor necrosis factor-α (TNF-α) and interleukine-6 are largely produced by abdominal fat and have been related to insulin resistance. TNF-α interferes on insulin metabolism cascade, activating proinflammatory pathways that impair insulin signalling at the level of the insulin receptor substrate proteins, causing insulin resistance [25]. Besides, TNF-α inhibits adiponectin expression, causes elevation in serum free fat acid by stimulation of lipolysis and hepatic lipogenesis, contributing for insulin resistance and may lead to development of NAFLD [4,23,26], justifying our findings. Our results indicated that IAAT was more important than SCAT in the genesis of the MS and NAFLD [27]. Although SCAT has been associated with blood pressure and, in fact, the above mentioned pathways are strongly related to endothelial dysfunction [4], the significance was lost after the adjustments. Various studies have shown that, the increase of free fat acid in circulation corroborates with formation of low density lipoproteins (LDL) e very low density lipoproteins (VLDL) associated to reduction on high density lipoproteins (HDL) and very high density lipoproteins (VHDL), which results in atherosclerosis and elevation of arterial pressure [28,29]. Limitations of the study should be highlighted. The cross-sectional design constitutes a limitation because it is not possible to establish a causality of the involved variables. Moreover, the absence of pro-inflammatory adipokines analysis should be considered in the interpretation of the findings. In addition, the NAFLD was not diagnosed by liver biopsy, which is considered the gold standard, otherwise, the ultrasound is considered a useful tool for initial screening [30,31], based on parameters such as hepatorenal echo contrast and liver echogenicity [32]. Another reason is the unclear perform of serum aminotransferases, such as ALT and AST to diagnosis NAFLD in adults and children [33]. Furthermore, interventional studies are necessary to offer consistent support to our proposed model of analysis.

Conclusions

In summary, our findings identified that, in obese adolescents, intra-abdominal fat seems to be more relevant to the development of MS and NAFLD than subcutaneous fat, and these results are independent of possible confounding variables. However, future studies with larger sample are necessary to confirm this evidence and perhaps, suggest a cut off of visceral fat to predict MS and NAFLD.

Abbreviations

NAFLD: Nonalcohoolic fatty liver disease; MS: Metabolic syndrome; IAAT: Intra-abdominal adipose tissue; SCAT: Subcutaneous adipose tissue; BMI: Body mass index; HOMA-IR: Homeostasis model assessment-insulin resistance; BW: Body weight; %BF: Percentage of body fat; TFM: Trunk fat mass; TC: Total cholesterol; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low density lipoproteins; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; EBP: Elevated blood pressure; TNF-α: Tumor necrosis factor-α; VLDL: Very low density lipoproteins.

Competing interests

The authors declare no competing interests.

Authors’ contributions

LSS participated in the design of the study, was the main responsible for collection, analysis and interpretation of data, and also drafting the manuscript. PAM and BMMA carried out the Dual energy X-ray absorptiometry involved in analysis and interpretation of data and drafted the manuscript. PMS carried out the immunoassays and also in critical revision of the paper. RAF participated in the design of the study and performed the statistical analysis. DGDC participated in the design of the study and review the manuscript. IFFJ conceived of the study and involved in revising the manuscript critically for important intellectual content. All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2431/13/115/prepub
  31 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Obesity, insulin resistance and the metabolic syndrome.

Authors:  Alan Sinaiko
Journal:  J Pediatr (Rio J)       Date:  2007 Jan-Feb       Impact factor: 2.197

Review 3.  [Prevalence of metabolic syndrome in adolescents: a systematic review].

Authors:  Augusto César Ferreira de Moraes; Camila Sanchez Fulaz; Edna Regina Netto-Oliveira; Felipe Fossati Reichert
Journal:  Cad Saude Publica       Date:  2009-06       Impact factor: 1.632

4.  Nonalcoholic fatty liver disease as a comorbidity of childhood obesity.

Authors:  Nicole J Barshop; Cameron S Francis; Jeffrey B Schwimmer; Joel E Lavine
Journal:  Ped Health       Date:  2009-06-01

5.  Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD.

Authors:  Angela Shannon; Naim Alkhouri; Christine Carter-Kent; Lidia Monti; Rita Devito; Rocio Lopez; Ariel E Feldstein; Valerio Nobili
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-08       Impact factor: 2.839

6.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

Review 7.  eNOS, metabolic syndrome and cardiovascular disease.

Authors:  Paul L Huang
Journal:  Trends Endocrinol Metab       Date:  2009-07-31       Impact factor: 12.015

Review 8.  Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.

Authors:  M Lorenzo; S Fernández-Veledo; R Vila-Bedmar; L Garcia-Guerra; C De Alvaro; I Nieto-Vazquez
Journal:  J Anim Sci       Date:  2007-10-16       Impact factor: 3.159

9.  Short- and long-term beneficial effects of a multidisciplinary therapy for the control of metabolic syndrome in obese adolescents.

Authors:  Danielle Arisa Caranti; Marco Túlio de Mello; Wagner L Prado; Lian Tock; Kãli O Siqueira; Aline de Piano; Mara C Lofrano; Dejaldo M J Cristofalo; Henrique Lederman; Sérgio Tufik; Ana R Dâmaso
Journal:  Metabolism       Date:  2007-09       Impact factor: 8.694

10.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06
View more
  16 in total

1.  Ethnic and sex differences in fatty liver on cardiac computed tomography: the multi-ethnic study of atherosclerosis.

Authors:  Rajesh Tota-Maharaj; Michael J Blaha; Irfan Zeb; Ronit Katz; Ron Blankstein; Roger S Blumenthal; Matthew J Budoff; Khurram Nasir
Journal:  Mayo Clin Proc       Date:  2014-03-07       Impact factor: 7.616

2.  Comparison of Associations of DXA and CT Visceral Adipose Tissue Measures With Insulin Resistance, Lipid Levels, and Inflammatory Markers.

Authors:  John T Schousboe; Lisa Langsetmo; Ann V Schwartz; Brent C Taylor; Tien N Vo; Allyson M Kats; Elizabeth Barrett-Connor; Eric S Orwoll; Lynn M Marshall; Iva Miljkovic; Nancy E Lane; Kristine E Ensrud
Journal:  J Clin Densitom       Date:  2017-02-24       Impact factor: 2.617

3.  Factors early in life associated with hepatic steatosis.

Authors:  Sabrina Xin Zi Quek; Eunice Xiang-Xuan Tan; Yi Ping Ren; Mark Muthiah; Evelyn Xiu Ling Loo; Elizabeth Huiwen Tham; Kewin Tien Ho Siah
Journal:  World J Hepatol       Date:  2022-06-27

4.  Associations among sugar sweetened beverage intake, visceral fat, and cortisol awakening response in minority youth.

Authors:  G E Shearrer; M J Daniels; C M Toledo-Corral; M J Weigensberg; D Spruijt-Metz; J N Davis
Journal:  Physiol Behav       Date:  2016-09-19

5.  Passive Smoke Exposure and Its Effects on Cognition, Sleep, and Health Outcomes in Overweight and Obese Children.

Authors:  Catherine L Davis; Martha S Tingen; Jenny Jia; Forrest Sherman; Celestine F Williams; Kruti Bhavsar; Nancy Wood; Jessica Kobleur; Jennifer L Waller
Journal:  Child Obes       Date:  2016-01-26       Impact factor: 2.992

Review 6.  Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Valerio Nobili; Anna Alisi; Kimberly P Newton; Jeffrey B Schwimmer
Journal:  Gastroenterology       Date:  2016-03-19       Impact factor: 22.682

Review 7.  NAFLD in children: new genes, new diagnostic modalities and new drugs.

Authors:  Valerio Nobili; Anna Alisi; Luca Valenti; Luca Miele; Ariel E Feldstein; Naim Alkhouri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-07-05       Impact factor: 46.802

Review 8.  Obesity and Metabolic Care of Children of South Asian Ethnicity in Western Society.

Authors:  Ramya Sivasubramanian; Sonali Malhotra; Angela K Fitch; Vibha Singhal
Journal:  Children (Basel)       Date:  2021-05-25

Review 9.  A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence.

Authors:  Jonathan L Temple; Paul Cordero; Jiawei Li; Vi Nguyen; Jude A Oben
Journal:  Int J Mol Sci       Date:  2016-06-15       Impact factor: 5.923

10.  Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Su Jong Yu; Won Kim; Donghee Kim; Jung-Hwan Yoon; Kyoungbun Lee; Jung Ho Kim; Eun Ju Cho; Jeong-Hoon Lee; Hwi Young Kim; Yoon Jun Kim; Chung Yong Kim
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.